Skip to main content
Figure 7 | Journal of Translational Medicine

Figure 7

From: Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivo

Figure 7

Anti-PLSCR1 represses tumorigenesis by inhibiting EGFR-related downstream signaling. (A) The expression of EGFR, Src, PLSCR1, Shc, and Erks was evaluated with western blotting after the cells were treated with NP1 or isotype-control IgG. (B) Phosphorylation of Src, Shc, and Erks decreased following NP1 treatment in HT29 cells.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us